
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.680 | 2.680 | 0.000 |
Shares | 97.320 | 97.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.158 | 16.033 |
Price to Book | 3.718 | 2.672 |
Price to Sales | 5.527 | 2.067 |
Price to Cash Flow | 14.742 | 10.257 |
Dividend Yield | 0.572 | 2.776 |
5 Years Earnings Growth | 6.570 | 12.255 |
Number of long holdings: 83
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 6.91 | 455.45 | -1.00% | |
Amgen | US0311621009 | 6.10 | 295.22 | -0.70% | |
Gilead | US3755581036 | 5.97 | 109.98 | -1.85% | |
Regeneron Pharma | US75886F1075 | 4.90 | 529.24 | +1.42% | |
Alnylam | US02043Q1076 | 4.72 | 307.99 | +1.09% | |
BioNTech | US09075V1026 | 3.03 | 106.57 | +1.57% | |
BeiGene ADS | US07725L1026 | 2.84 | 269.63 | -2.50% | |
Insmed | US4576693075 | 2.64 | 98.73 | +1.91% | |
Ascendis Pharma AS | US04351P1012 | 2.60 | 170.80 | -0.07% | |
Biomarin Pharma | US09061G1013 | 2.54 | 56.22 | -1.85% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities R EUR Acc | 2.99B | -8.67 | 11.18 | 11.32 | ||
Cleome Index USA Equities Y EUR Acc | 2.99B | -9.07 | 10.01 | 10.41 | ||
Cleome Index USA Equities Z EUR Acc | 2.99B | -14.27 | 8.51 | 11.36 | ||
LU2197358042 | 2.99B | -8.59 | 11.42 | - | ||
Candriam Equities L Global Demograp | 2.11B | -5.95 | 8.73 | 8.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review